Deciphera Pharmaceuticals (DCPH) Stock Forecast for 2025, 2026, 2027. Sell or Buy Prediction







Understanding Accounting and Bookkeeping Services for Business Success

June 10, 2025 Understanding Accounting and Bookkeeping Services for Business Success

Every successful business relies on accurate financial records. From managing cash flow to ensuring compliance with tax regulations, reliable accounting and bookkeeping services…
How much does a Turkish passport cost?

May 27, 2025 How much does a Turkish passport cost?

Turkish citizenship comes with numerous benefits. Once granted, a foreigner can enter 126 countries visa-free, enjoy high-quality healthcare and favorable tax regimes, and…
How Measurement and Mix Modeling Drive Better Business Decisions

May 22, 2025 How Measurement and Mix Modeling Drive Better Business Decisions

In today’s data-driven business landscape, the ability to accurately measure and optimize marketing efforts has become a critical competitive advantage. As marketing evolves,…
Are you making these mistakes when analyzing candlestick patterns?

May 22, 2025 Are you making these mistakes when analyzing candlestick patterns?

Trading is a very popular endeavor these days, and for good reason, as it is widely accessible and allows individuals to generate additional…
Oleksandr Orlovskyi: Reviews, Biography, and All About Cryptocurrency

April 23, 2025 Oleksandr Orlovskyi: Reviews, Biography, and All About Cryptocurrency

What defines a successful crypto expert? The amount of money earned, the number of luxury cars and international real estate? The presence of…

Deciphera Pharmaceuticals (DCPH) Stock Forecast for 2025, 2026, 2027. Sell or Buy?

Updated: June 22, 2025 (04:53)

Sector: Healthcare

The share price of Deciphera Pharmaceuticals, Inc. (DCPH) now

This company is DELISTED
Latest session on the 12th of July for
Deciphera Pharmaceuticals, Inc. is negative
Trading Volume: 600
Open: 25.59 /  High: 25.59 /  Low: 25.59
Current value: $25.59

Are you interested in Deciphera Pharmaceuticals, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Deciphera Pharmaceuticals stock price in 2025, 2026, 2027. How much will one Deciphera Pharmaceuticals share be worth in 2025 - 2027?

When should I take profit in Deciphera Pharmaceuticals stock? When should I record a loss on Deciphera Pharmaceuticals stock? What are analysts' forecasts for Deciphera Pharmaceuticals stock? What is the future of Deciphera Pharmaceuticals stock? We forecast Deciphera Pharmaceuticals stock performance using neural networks based on historical data on Deciphera Pharmaceuticals stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Deciphera Pharmaceuticals stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Deciphera Pharmaceuticals shares. This happens once a day.


Historical and forecast chart of Deciphera Pharmaceuticals stock

The chart below shows the historical price of Deciphera Pharmaceuticals stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Deciphera Pharmaceuticals stock price can be found in the table below.

No data

Long-term forecasts by years.

Deciphera Pharmaceuticals, Inc. is a clinical research biopharmaceutical company.

The company develops drugs designed to improve the lives of cancer patients. Her drug candidates include DCC-2618, DCC-3014 and (Rebastinib) Rebastinib. The platform of kinase switching inhibitors developed by the Company suppresses the process of kinase activation. DCC-2618 is an orally administered inhibitor of kinase switching control for the treatment of gastrointestinal stromal tumors (GIST), advanced systemic mastocytosis (ASM), gliomas including glioblastoma multiforme (GBM), and other solid tumors caused by the pan-KIT or PDGFR gene alpha. DCC-3014 is an orally administered potent and highly selective colony stimulating factor receptor 1 (CSF1R) inhibitor. Rebastinib is a potent and selective oral immunokinase inhibitor of TIE2. Rebastinib binds tightly to the binding region (pocket) of the TIE2 switch, stabilizing the inhibitory switch and displacing the activation switch to block TIE2 signaling.

Trending Themes in the Healthcare Sector

Deciphera Pharmaceuticals daily forecast for a month

Date Target Pes. Opt. Vol., %
Jun 24 28.07 26.97 28.61 6.09
Jun 25 28.50 27.75 29.20 5.24
Jun 26 27.67 26.66 28.17 5.66
Jun 27 27.99 27.10 28.79 6.25
Jun 28 28.65 28.19 29.11 3.25
Jun 29 28.42 28.05 28.73 2.43
Jun 30 28.32 27.33 28.83 5.49
Jul 01 28.08 26.99 28.92 7.18
Jul 02 28.71 28.10 29.83 6.18
Jul 03 29.17 28.21 29.65 5.12
Jul 04 28.95 28.61 29.89 4.50
Jul 05 28.87 28.52 29.46 3.29
Jul 06 30.29 29.64 30.95 4.39
Jul 07 30.28 29.46 30.66 4.06
Jul 08 30.92 30.10 31.92 6.06
Jul 09 31.05 30.60 32.06 4.77
Jul 10 30.62 29.96 31.71 5.83
Jul 11 31.54 30.88 32.48 5.21
Jul 12 31.32 30.36 32.37 6.60
Jul 13 31.83 30.61 32.18 5.15
Jul 14 32.31 31.21 32.89 5.38
Jul 15 32.18 31.44 33.47 6.45
Jul 16 32.54 31.92 33.32 4.38
Jul 17 32.67 31.95 33.60 5.16
Jul 18 32.18 31.63 33.06 4.53
Jul 19 31.79 30.76 32.59 5.94
Jul 20 32.39 31.36 33.64 7.28
Jul 21 31.99 30.95 33.24 7.39
Jul 22 30.50 29.53 31.66 7.23
Jul 23 29.28 28.29 29.85 5.54

Deciphera Pharmaceuticals Daily Price Targets


Deciphera Pharmaceuticals Stock Forecast 06-24-2025.

Forecast target price for 06-24-2025: $28.07.
Positive dynamics for Deciphera Pharmaceuticals shares will prevail with possible volatility of 5.738%.
Pessimistic target level: 26.97
Optimistic target level: 28.61

Deciphera Pharmaceuticals Stock Forecast 06-25-2025.

Forecast target price for 06-25-2025: $28.50.
Positive dynamics for Deciphera Pharmaceuticals shares will prevail with possible volatility of 4.978%.
Pessimistic target level: 27.75
Optimistic target level: 29.20

Deciphera Pharmaceuticals Stock Forecast 06-26-2025.

Forecast target price for 06-26-2025: $27.67.
Negative dynamics for Deciphera Pharmaceuticals shares will prevail with possible volatility of 5.354%.
Pessimistic target level: 26.66
Optimistic target level: 28.17

Deciphera Pharmaceuticals Stock Forecast 06-27-2025.

Forecast target price for 06-27-2025: $27.99.
Positive dynamics for Deciphera Pharmaceuticals shares will prevail with possible volatility of 5.882%.
Pessimistic target level: 27.10
Optimistic target level: 28.79

Deciphera Pharmaceuticals Stock Forecast 06-28-2025.

Forecast target price for 06-28-2025: $28.65.
Positive dynamics for Deciphera Pharmaceuticals shares will prevail with possible volatility of 3.150%.
Pessimistic target level: 28.19
Optimistic target level: 29.11

Deciphera Pharmaceuticals Stock Forecast 06-29-2025.

Forecast target price for 06-29-2025: $28.42.
Negative dynamics for Deciphera Pharmaceuticals shares will prevail with possible volatility of 2.374%.
Pessimistic target level: 28.05
Optimistic target level: 28.73

DCPH (DCPH) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jul. 28.97 25.72 33.54 23.32
Jul. 30.71 29.48 34.76 15.19
Aug. 29.85 26.98 34.08 20.84
Oct. 25.31 22.58 27.64 18.32
Oct. 25.46 23.42 29.54 20.69
Dec. 28.01 25.09 32.15 21.95
Dec. 25.43 21.46 27.11 20.83

Deciphera Pharmaceuticals forecast for this year


Deciphera Pharmaceuticals Stock Prediction for Jul 2025

An uptrend is forecast for this month with an optimal target price of $28.9679. Pessimistic: $25.72. Optimistic: $33.54


Deciphera Pharmaceuticals Stock Prediction for Jul 2025

An uptrend is forecast for this month with an optimal target price of $30.706. Pessimistic: $29.48. Optimistic: $34.76


Deciphera Pharmaceuticals Stock Prediction for Aug 2025

An downtrend is forecast for this month with an optimal target price of $29.8462. Pessimistic: $26.98. Optimistic: $34.08


Deciphera Pharmaceuticals Stock Prediction for Oct 2025

An downtrend is forecast for this month with an optimal target price of $25.3096. Pessimistic: $22.58. Optimistic: $27.64


Deciphera Pharmaceuticals Stock Prediction for Oct 2025

An uptrend is forecast for this month with an optimal target price of $25.4614. Pessimistic: $23.42. Optimistic: $29.54


Deciphera Pharmaceuticals Stock Prediction for Dec 2025

An uptrend is forecast for this month with an optimal target price of $28.0076. Pessimistic: $25.09. Optimistic: $32.15


Deciphera Pharmaceuticals Stock Prediction for Dec 2025

An downtrend is forecast for this month with an optimal target price of $25.4309. Pessimistic: $21.46. Optimistic: $27.11



Deciphera Pharmaceuticals (DCPH) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 24.46 21.43 27.25 21.36
Mar 22.31 20.39 25.21 19.12
Mar 23.96 21.95 26.98 18.65
May 26.17 23.08 29.10 20.68
May 23.34 21.38 26.28 18.65
Jul 24.70 21.24 26.87 20.96
Jul 25.93 22.51 27.64 18.57
Aug 31.12 28.32 32.48 12.84
Oct 35.53 29.92 37.31 19.81
Oct 34.11 32.27 39.23 17.74
Dec 38.41 33.11 43.17 23.31
Dec 38.33 34.58 42.86 19.32

Deciphera Pharmaceuticals (DCPH) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 35.88 33.44 39.25 14.81
Mar 37.96 34.85 43.50 19.90
Mar 39.86 33.96 45.68 25.65
May 33.32 30.79 35.99 14.44
May 37.99 35.78 40.57 11.80
Jul 37.68 34.52 41.90 17.63
Jul 40.02 34.02 43.70 22.16
Aug 41.14 37.77 46.49 18.76
Oct 42.87 40.90 45.44 10.00
Oct 34.72 32.71 40.14 18.51
Dec 34.10 30.42 36.35 16.32
Dec 34.78 32.07 38.75 17.24

Deciphera Pharmaceuticals information and performance

Deciphera Pharmaceuticals Address

N/A

Market Capitalization: N/A $

Market capitalization of the Deciphera Pharmaceuticals, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of DCPH shares in the company outstanding by the market price of one share.

EBITDA: N/A $

EBITDA of Deciphera Pharmaceuticals is earnings before interest, income tax and depreciation of assets.

PE Ratio: N/A

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: N/A

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: N/A

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: N/A

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: N/A

Enterprise Value (EV) /Revenue

EV To EBITDA: N/A

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: N/A

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

FAQ (Frequently Asked Questions about Deciphera Pharmaceuticals Stock)

Should I Buy Deciphera Pharmaceuticals Shares in 2025 year?

The maximum forecasted share price for next year is $38.41, which is $12.82 higher than the current stock price. By investing in Deciphera Pharmaceuticals shares today for a one-year period, you could achieve a profit of 50.10%. With an investment horizon of up to two years, the target share price is $42.87. resulting in a profit of 67.52% ($17.28 per share).

Does Deciphera Pharmaceuticals pay dividends?

No, it does not

Which economic sector do Deciphera Pharmaceuticals's shares belong to?

Deciphera Pharmaceuticals's shares belong to the "Healthcare" sector of economic.

Which other securities belong to the same sector as Deciphera Pharmaceuticals's shares?

You can view all the stocks that are part of the same sector as Deciphera Pharmaceuticals's shares in the Healthcare section.


Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.